Vita Life Sciences (ASX:VSC) today released their annual report. The report in my eyes is very pleasing and their expansion across Asia seems to be driving a larger portion of their revenue yoy. Their ROE is increasing at a healthy pace and free cash flows have risen over 250% compared to their previous year. The EPS has roughly doubled and their fundamentals are looking strong. I've visited local chemists to find out more about their Australian products and I've discovered they don't compete with Blackmores in general as they offer different products. I wonder how the market will take this over the next few months.
No comments:
Post a Comment